Continuing chronic beta-blockade in the acute phase of severe sepsis and septic shock is associated with decreased mortality rates up to 90 days C. Fuchs, S. Wauschkuhn, C. Scheer, M. Vollmer, K. Meissner, S.-O. Kuhn, K. Hahnenkamp, A. Morelli, M. Gründling, S. Rehberg British Journal of Anaesthesia Volume 119, Issue 4, Pages 616-625 (October 2017) DOI: 10.1093/bja/aex231 Copyright © 2017 The Author(s) Terms and Conditions
Fig 1 Study flow diagram. SIRS, Systemic Inflammatory Response Syndrome. British Journal of Anaesthesia 2017 119, 616-625DOI: (10.1093/bja/aex231) Copyright © 2017 The Author(s) Terms and Conditions
Fig 2 Kaplan-Meier estimates of the survival functions. Survival functions of the first 90 days after sepsis onset are given for patients with continued (red) and discontinued (blue) beta-blocker therapy with 95% confidence bounds. The survival information till 90 days is right censored (indicated by plus sign). British Journal of Anaesthesia 2017 119, 616-625DOI: (10.1093/bja/aex231) Copyright © 2017 The Author(s) Terms and Conditions